Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a randomized, single-center clinical trial that will compare the efficacy of two substances used in the submucosal cushion formation stage of endoscopic submucosal resections of early esophageal malignant neoplasms. Such substances are hyaluronic acid in the form of TS-905 Blue Eyeₒ and hydroxyethylamide (Voluven®).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Rak przełyku w wczesnym stadium z wskazaniem do zabiegu endoskopowego potwierdzonego przez zespół specjalistów
- •Podpisana świadoma zgoda na udział w badaniu
✗ Disqualifies
- •Pozostałe lub nawrotowe ogniska nowotworu w przełyku
- •Wrzody w przełyku
- •Poważne choroby serca, nerek lub wątroby
- •Uczulenie na kwas hialuronowy
- •Ciąża lub karmienie piersią
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Instituto do Câncer do Estado de São Paulo
São Paulo, Brazil
Trial contact
Fauze Maluf-Filho, PhD
Pierre Pirchner
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.